10.1371/journal.pone.0108052.t001 Carolin Reischauer Carolin Reischauer Johannes Malte Froehlich Johannes Malte Froehlich Miklos Pless Miklos Pless Christoph Andreas Binkert Christoph Andreas Binkert Dow-Mu Koh Dow-Mu Koh Andreas Gutzeit Andreas Gutzeit Specific therapy, length of progression-free interval, and lesion cross section size on CT before and after treatment for each patient. Public Library of Science 2014 Cantonal Research Ethics Committee monitoring treatment response tumor size voxel treatment response Feasibility Study ObjectiveThe aim fdm chemotherapy percentage adc ct treatment response.ResultsRepeated measures ANOVA 2014-10-07 03:17:45 Dataset https://plos.figshare.com/articles/dataset/_Specific_therapy_length_of_progression_free_interval_and_lesion_cross_section_size_on_CT_before_and_after_treatment_for_each_patient_/1196740 <p>* The patient deceased prior to tumor progression due to causes unrelated to lung cancer.</p><p>Specific therapy, length of progression-free interval, and lesion cross section size on CT before and after treatment for each patient.</p>